Findings

What do systematic reviews say?

4,756 questions · 11,779 findings · 747 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3,205 · 27.2%GRADE not reported 628 · 5.3%Very low 3,261 · 27.7%Low 2,913 · 24.7%Moderate 1,453 · 12.3%High 319 · 2.7%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Self‐management interventions vs usual care

COPD exacerbations · patients with chronic obstructive pulmonary disease

1 finding from 1 review · compare the 2 reviews

Self‐management interventions for people with chronic obstructive pulmonary disease 2022 · Cochrane Headline outcomes only
no estimate extracted
1401 participants
Moderate

Mental function interventions vs control

Primary outcome · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mental function interventions vs control

Activities of daily living · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury

The review found no eligible studies for this question.

2 findings from 1 review

Non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain… 2021 · Cochrane Headline outcomes only
SMD 0.32
1 study · 24 participants
Very low

Mental function interventions vs control

Secondary outcomes · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mental function interventions vs control

Neglect outcomes: effects persisting at least 1 month post intervention · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mental function interventions vs control

Neglect outcomes: immediate effects · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury

It is very uncertain whether mental function interventions changes neglect outcomes: immediate effects compared with any control (very low certainty).

1 finding from 1 review

Non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain… 2021 · Cochrane Headline outcomes only
SMD 0.1
3 studies · 60 participants
Very low

Mental function interventions vs control

Adverse events · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pharmacological interventions vs placebo

GABA analogue VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 297 participants
High

Pharmacological interventions vs placebo

Montelukast Duo score (0 to 81) and VAS (0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 87 participants
Moderate

Pharmacological interventions vs placebo

Sertraline VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Low

Pharmacological interventions vs placebo

Lidocaine Itch relief · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 16 participants
Very low

Pharmacological interventions vs placebo

Sodium thalidomide Itch relief · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 33 participants
Very low

Pharmacological interventions vs placebo

Doxepin Itch relief · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 48 participants
Low

Pharmacological interventions vs placebo

Ondansetron VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 183 participants
High

Pharmacological interventions vs placebo

Kappa‐opioid agonist VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 661 participants
High

Pharmacological interventions vs placebo

Mu‐opioid antagonist VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 62 participants
Low

Pharmacological interventions vs placebo

Nalbuphine VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 179 participants
Low

Pharmacological interventions vs placebo

Cromolyn VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Low

Pharmacological interventions vs placebo

Nicotinamide VAS(0 to 5 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Low

Pharmacological interventions vs placebo

EPO Duo score(0 to 40) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low